Suppr超能文献

通过创新的预测、预防和个性化医疗方法实现更大的炎症通路——高临床潜力。

The greater inflammatory pathway-high clinical potential by innovative predictive, preventive, and personalized medical approach.

作者信息

Maturo Maria Giovanna, Soligo Marzia, Gibson Greg, Manni Luigi, Nardini Christine

机构信息

1Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.

2Institute of Translational Pharmacology, Consiglio Nazionale delle Ricerche (CNR), Rome, Italy.

出版信息

EPMA J. 2019 Dec 10;11(1):1-16. doi: 10.1007/s13167-019-00195-w. eCollection 2020 Mar.

Abstract

BACKGROUND AND LIMITATIONS

Impaired wound healing (WH) and chronic inflammation are hallmarks of non-communicable diseases (NCDs). However, despite WH being a recognized player in NCDs, mainstream therapies focus on (un)targeted damping of the inflammatory response, leaving WH largely unaddressed, owing to three main factors. The first is the complexity of the pathway that links inflammation and wound healing; the second is the dual nature, local and systemic, of WH; and the third is the limited acknowledgement of genetic and contingent causes that disrupt physiologic progression of WH.

PROPOSED APPROACH

Here, in the frame of Predictive, Preventive, and Personalized Medicine (PPPM), we integrate and revisit current literature to offer a novel systemic view on the cues that can impact on the fate (acute or chronic inflammation) of WH, beyond the compartmentalization of medical disciplines and with the support of advanced computational biology.

CONCLUSIONS

This shall open to a broader understanding of the causes for WH going awry, offering new operational criteria for patients' stratification (prediction and personalization). While this may also offer improved options for targeted prevention, we will envisage new therapeutic strategies to reboot and/or boost WH, to enable its progression across its physiological phases, the first of which is a transient acute inflammatory response versus the chronic low-grade inflammation characteristic of NCDs.

摘要

背景与局限性

伤口愈合受损(WH)和慢性炎症是非传染性疾病(NCDs)的标志。然而,尽管伤口愈合在非传染性疾病中是一个公认的因素,但主流疗法主要集中于对炎症反应进行(非)靶向性抑制,由于三个主要因素,伤口愈合在很大程度上未得到解决。第一个因素是连接炎症和伤口愈合的途径的复杂性;第二个因素是伤口愈合的局部和全身双重性质;第三个因素是对破坏伤口愈合生理进程的遗传和偶然原因的认识有限。

提议的方法

在此,在预测、预防和个性化医学(PPPM)的框架内,我们整合并重新审视当前文献,以提供一种新颖的系统观点,探讨在超越医学学科划分并借助先进计算生物学支持的情况下,哪些线索会影响伤口愈合的结局(急性或慢性炎症)。

结论

这将有助于更广泛地理解伤口愈合出现问题的原因,为患者分层(预测和个性化)提供新的操作标准。虽然这也可能为靶向预防提供更好的选择,但我们将设想新的治疗策略来重启和/或促进伤口愈合,使其在生理阶段中进展,其中第一个阶段是短暂的急性炎症反应,与非传染性疾病的慢性低度炎症特征相对。

相似文献

10
Clinical multi-omics strategies for the effective cancer management.临床多组学策略在癌症有效管理中的应用。
J Proteomics. 2018 Sep 30;188:97-106. doi: 10.1016/j.jprot.2017.08.010. Epub 2017 Aug 15.

引用本文的文献

1
Mechanotransduction and inflammation: An updated comprehensive representation.机械转导与炎症:最新综合阐述
Mechanobiol Med. 2024 Dec 14;3(1):100112. doi: 10.1016/j.mbm.2024.100112. eCollection 2025 Mar.
2
Predictive power of epigenetic age - opportunities and cautions.表观遗传年龄的预测能力——机遇与警示
Epigenomics. 2025 Feb;17(2):75-77. doi: 10.1080/17501911.2024.2433409. Epub 2024 Nov 24.

本文引用的文献

3
A blood-based prognostic biomarker in IBD.炎症性肠病的一种基于血液的预后生物标志物。
Gut. 2019 Aug;68(8):1386-1395. doi: 10.1136/gutjnl-2019-318343. Epub 2019 Apr 27.
8
A guide to deep learning in healthcare.深度学习在医疗保健中的应用指南。
Nat Med. 2019 Jan;25(1):24-29. doi: 10.1038/s41591-018-0316-z. Epub 2019 Jan 7.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验